These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22069240)
1. Serological antibodies in inflammatory bowel disease: a systematic review. Prideaux L; De Cruz P; Ng SC; Kamm MA Inflamm Bowel Dis; 2012 Jul; 18(7):1340-55. PubMed ID: 22069240 [TBL] [Abstract][Full Text] [Related]
2. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. Bonneau J; Dumestre-Perard C; Rinaudo-Gaujous M; Genin C; Sparrow M; Roblin X; Paul S Autoimmun Rev; 2015 Mar; 14(3):231-45. PubMed ID: 25462578 [TBL] [Abstract][Full Text] [Related]
3. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202 [TBL] [Abstract][Full Text] [Related]
4. Serological markers of inflammatory bowel disease. Kuna AT Biochem Med (Zagreb); 2013; 23(1):28-42. PubMed ID: 23457764 [TBL] [Abstract][Full Text] [Related]
5. ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease? Zhou G; Song Y; Yang W; Guo Y; Fang L; Chen Y; Liu Z Dig Dis; 2016; 34(1-2):90-7. PubMed ID: 26982193 [TBL] [Abstract][Full Text] [Related]
6. [Relevance of serologic studies in inflammatory bowel diseases]. Papp M; Altorjay I; Lakatos PL Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404 [TBL] [Abstract][Full Text] [Related]
7. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543 [TBL] [Abstract][Full Text] [Related]
8. New serological biomarkers of inflammatory bowel disease. Li X; Conklin L; Alex P World J Gastroenterol; 2008 Sep; 14(33):5115-24. PubMed ID: 18777587 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
10. New serologic markers for inflammatory bowel disease diagnosis. Dotan I Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866 [TBL] [Abstract][Full Text] [Related]
11. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course. Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876 [TBL] [Abstract][Full Text] [Related]
12. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323 [TBL] [Abstract][Full Text] [Related]
13. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509 [TBL] [Abstract][Full Text] [Related]
18. Serological markers in inflammatory bowel disease: a review of their clinical utility. Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch. Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628 [TBL] [Abstract][Full Text] [Related]
20. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease. Goren I; Yahav L; Tulchinsky H; Dotan I Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]